Partial_JJ reconstitution_NN of_IN human_JJ RNase_NP P_NN in_IN HeLa_NP cells_NNS between_IN its_PP$ RNA_NP subunit_NN with_IN an_DT affinity_NN tag_NN and_CC the_DT intact_JJ protein_NN components_NNS An_DT RNA_NP affinity_NN tag_NN was_VBD incorporated_VBN into_IN the_DT RNA_NP subunit_NN of_IN human_JJ nuclear_JJ RNase_NP P._NP The_DT tagged_VBN RNA_NP assembled_VBN with_IN the_DT protein_NN components_NNS of_IN RNase_NP P_NN inside_IN HeLa_NP cells_NNS to_TO generate_VB an_DT active_JJ enzyme_NN ._SENT Because_IN of_IN the_DT specificity_NN of_IN the_DT RNA_NP tag_NN to_TO streptavidin_NN ,_, the_DT reconstituted_VBN complex_NN could_MD be_VB separated_VBN from_IN the_DT native_JJ enzyme_NN and_CC other_JJ ribonucleoproteins_NNS (_( particularly_RB RNase_NP MRP_NP )_) by_IN streptavidin_NN agarose_NN chromatography_NN and_CC could_MD be_VB recovered_VBN by_IN the_DT eluting_VBG agent_NN ,_, biotin_NN ._SENT A_DT mutant_NN ,_, tagged_VBN RNase_NP P_NN RNA_NP ,_, whose_WP$ P3_JJ domain_NN was_VBD partially_RB replaced_VBN ,_, could_MD not_RB reconstitute_VB with_IN the_DT proteins_NNS to_TO yield_VB an_DT active_JJ enzyme_NN ._SENT The_DT P3_NP domain_NN ,_, therefore_RB ,_, is_VBZ critical_JJ for_IN the_DT structure_NN and_CC function_NN of_IN RNase_NP P._NP Ribonuclease_NP P_NN (_( RNase_NP P_NN )_) is_VBZ an_DT essential_JJ enzyme_NN required_VBN for_IN the_DT processing_NN of_IN the_DT 5_CD '_POS termini_NNS of_IN precursor_NN tRNAs_NNS in_IN all_DT living_VBG organisms_NNS ._SENT The_DT eubacterial_JJ RNase_NP P_NN consists_VBZ of_IN one_CD RNA_NP subunit_NN and_CC one_CD protein_NN subunit_NN ._SENT The_DT RNA_NP subunit_NN retains_VBZ its_PP$ catalytic_JJ function_NN in_IN a_DT high_JJ concentration_NN of_IN salt_NN in_IN vitro_NN in_IN the_DT absence_NN of_IN the_DT protein_NN subunit_NN ._SENT However_RB ,_, the_DT protein_NN component_NN facilitates_VBZ catalysis_NN under_IN physiological_JJ salt_NN concentrations_NNS and_CC is_VBZ required_VBN for_IN efficient_JJ tRNA_NN processing_NN in_IN vivo_RB ._SENT The_DT currently_RB characterized_VBN eukaryotic_NN (_( either_CC Saccharomyces_NP cerevisiae_NP or_CC Homo_NP sapiens_JJ )_) nuclear_JJ RNase_NP P_NN possesses_VBZ numerous_JJ protein_NN subunits_NN and_CC one_CD RNA_NP subunit_NN (_( ,_, )_) ._SENT Unlike_IN the_DT eubacterial_JJ enzyme_NN ,_, the_DT combination_NN of_IN human_JJ RNase_NP P_NN RNA_NP transcribed_VBD in_IN vitro_NN and_CC its_PP$ purified_VBN recombinant_JJ proteins_NNS expressed_VBN in_IN Escherichia_NP coli_NNS when_WRB mixed_VBN together_RB did_VBD not_RB achieve_VB an_DT active_JJ enzyme_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Total_JJ ,_, reliably_RB reproduced_VBN ,_, reconstitution_NN in_IN vitro_NN of_IN the_DT RNA_NP and_CC protein_NN subunits_NN of_IN the_DT eukaryotic_JJ RNase_NP P_NN has_VBZ not_RB been_VBN reported_VBN so_RB far_RB ._SENT An_DT RNA_NP aptamer_NN (_( S1_NP )_) has_VBZ been_VBN developed_VBN recently_RB to_TO bind_VB specifically_RB to_TO streptavidin_NN ._SENT The_DT RNA_NP subunit_NN of_IN yeast_NN nuclear_JJ RNase_NP P_NN was_VBD tagged_VBN with_IN the_DT streptavidin-binding_JJ element_NN and_CC the_DT tagged_VBN RNA_NP subunit_NN was_VBD shown_VBN to_TO be_VB able_JJ to_TO reconstitute_VB an_DT active_JJ enzyme_NN with_IN the_DT protein_NN subunits_NN in_IN vivo_RB ._SENT The_DT enzyme_NN could_MD be_VB isolated_VBN from_IN column_NN chromatography_NN by_IN elution_NN with_IN biotin_NN because_IN the_DT S1-binding_NP ability_NN to_TO streptavidin_NN agarose_NN beads_NNS is_VBZ much_RB lower_JJR than_IN that_IN of_IN biotin_NN ._SENT In_IN this_DT study_NN ,_, we_PP have_VBP shown_VBN that_IN the_DT RNA_NP affinity_NN tag_NN also_RB works_VBZ well_RB in_IN a_DT mammalian_JJ system_NN ,_, and_CC the_DT aptamer-tagged_JJ human_JJ nuclear_JJ RNase_NN P_NN could_MD be_VB immobilized_VBN to_TO streptavidin_NN agarose_NN from_IN crude_JJ cell_NN extracts_VBZ and_CC eluted_VBN with_IN biotin_NN under_IN mild_JJ conditions_NNS ._SENT In_IN addition_NN ,_, we_PP have_VBP applied_VBN this_DT method_NN to_TO the_DT study_NN of_IN an_DT essential_JJ protein-binding_NN domain_NN (_( P3_NP )_) of_IN the_DT RNase_NP P_NN RNA_NP from_IN HeLa_NP cells_NNS ._SENT Materials_NPS |_SYM Restriction_NN and_CC modification_NN enzymes_NNS were_VBD obtained_VBN from_IN New_NP England_NP Biolabs_NP ._SENT Radiochemicals_NNS were_VBD obtained_VBN from_IN Amersham_NP ._SENT Oligonucleotides_NNS were_VBD synthesized_VBN by_IN the_DT Keck_NP Facility_NP at_IN Yale_NP University_NP ._SENT Cloning_VBG and_CC mutagenesis_NN ._SENT Four_CD oligonucleotides_NNS ,_, oligo_NN 1_CD (_( AAAAG_NP GGAGT_NP CGACC_NP GACCA_NP GAATC_NP ATGCA_NP AGTGC_NP GTAAG_NP ATAGT_NP CGCGG_NP GCCGG_NP GGGCG_NP )_) ,_, oligo_NP 2_CD (_( TATTA_NP TGTGC_NP GTCTA_NP CATCT_NP AGACT_NP CATAA_NP AAGGC_NP CCCgg_NP cc_NN )_) ,_, oligo_NP 3_CD (_( GGGGC_NP CTTTT_NP ATGAG_NP TCTAG_NP ATGTA_NP GACGC_NP ACATA_NP ATACG_NP CCCCC_NP GGCCC_NP GCG_NP )_) ,_, oligo_NP 4_CD (_( TATCT_NP TACGC_NP ACTTG_NP CATGA_NP TTCTG_NP GTCGG_NP TCGAC_NP TCCCT_NP TTTgg_NP cc_NN )_) were_VBD annealed_VBN and_CC ligated_VBN with_IN pUC_NN /H1_JJ cut_NN by_IN ApaI_NP ._SENT The_DT bases_NNS represented_VBN by_IN lower_JJR case_NN letters_NNS facilitate_VBP cloning_VBG into_IN the_DT sticky_JJ ends_NNS of_IN the_DT restriction_NN enzymes_NNS ._SENT The_DT resulting_VBG plasmid_NN was_VBD then_RB digested_VBN by_IN EcoRI_NP and_CC SalI_NP ,_, and_CC the_DT similar400_JJ bp_NN fragment_NN was_VBD ligated_VBN to_TO the_DT plasmid_NN pDeltaEGFP_NN which_WDT is_VBZ derived_VBN from_IN pEGFP-N1_JJ (_( Clontech_NP )_) after_IN removal_NN of_IN the_DT gene_NN encoding_VBG EGFP_NP ._SENT The_DT final_JJ plasmid_NN was_VBD named_VBN as_IN pDeltaEGFP_NN --_: H1S1_JJ containing_VBG CMV_NP IE_NP promoter_NN ,_, the_DT gene_NN for_IN H1S1_NP (_( H1_NP RNA_NP with_IN S1_NP tag_NN )_) ,_, kanamycin_NN and_CC neomycin_NN selection_NN markers_NNS ,_, and_CC colE1_JJ and_CC SV40_JJ replication_NN origins_NNS ._SENT To_TO generate_VB the_DT deletion_NN of_IN P3_JJ domain_NN of_IN H1_NP RNA_NP ,_, two_CD oligonucleotides_NNS ,_, P3forward_NP (_( AGAAT_NP TCATA_NP GGGCG_NP GAGGG_NP AAGCT_NP CATCA_NP GTGGG_NP GATGT_NP CCCTT_NP GGGAA_NP GGT_NP )_) and_CC P3reverse_NP (_( AAGGA_NP TCCAA_NP TGGGC_NP GGAGG_NP AGAGT_NP AGT_NP )_) were_VBD used_VBN to_TO perform_VB PCR_NP with_IN pDeltaEGFP_NN --_: H1S1_NP as_IN template_NN ._SENT The_DT PCR_NP fragment_NN was_VBD cloned_VBN into_IN pDeltaEGFP_NN after_IN being_VBG digested_VBN by_IN EcoRI_NP to_TO get_VB the_DT plasmid_NN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT The_DT coding_VBG regions_NNS for_IN H1S1_NP and_CC H1S1DeltaP3_NP in_IN the_DT plasmids_NNS pDeltaEGFP_NN --_: H1S1_NP and_CC pDeltaEGFP_NP --_: H1S1DeltaP3_NP were_VBD confirmed_VBN by_IN DNA_NP sequencing_NP with_IN T7_NP Sequenase_NP (_( Amersham_NP )_) ._SENT Transfection_NN of_IN HeLa_NP cells_NNS |_SYM Transfection_NN of_IN the_DT plasmids_NNS into_IN HeLa_NP S3_NP cells_NNS was_VBD done_VBN with_IN SuperFect_NP transfection_NN reagent_NN (_( Qiagen_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS handbook_NN ._SENT The_DT cells_NNS were_VBD incubated_VBN for_IN 24_CD h_NN after_IN transfection_NN ,_, washed_VBN with_IN PBS_NP ,_, harvested_VBN and_CC stored_VBN at_IN --_: 80C_JJ ._SENT Purification_NN of_IN S1-tagged_JJ human_JJ RNase_NP P_NN |_SYM The_DT purification_NN was_VBD performed_VBN at_IN 4C_JJ as_RB described_VBN with_IN minor_JJ modifications_NNS ._SENT The_DT pellets_NNS of_IN cells_NNS (_( similar5_NN x_SYM 107_CD )_) were_VBD resuspended_VBN in_IN 0.5_CD ml_NN of_IN lysis_NN buffer_NN (_( 50_CD mM_NP HEPES_NP ,_, pH_NN 8.0_CD ,_, 10_CD mM_NP MgCl2_NP ,_, 100_CD mM_NP KCl_NP ,_, 1_CD mM_NP DTT_NP ,_, 10_CD %_NN glycerol_NN )_) with_IN the_DT Complete_JJ protease_NN inhibitor_NN cocktail_NN (_( Roche_NP )_) ._SENT The_DT mixture_NN was_VBD homogenized_VBN by_IN passing_VBG it_PP 15_CD times_NNS through_IN a_DT 25G7_JJ /8_CD needle_NN fitted_VBN into_IN a_DT 1_CD ml_NN syringe_NN ._SENT The_DT lysate_NN was_VBD centrifuged_VBN at_IN 16_CD 000_CD g_NN for_IN 30_CD min_NN ._SENT The_DT S16_NP cell_NN extract_NN was_VBD incubated_VBN and_CC rotated_VBN with_IN 50_CD microl_NN of_IN streptavidin_NN agarose_NN (_( Gibco_NP BRL_NP )_) overnight_RB in_IN a_DT 15_CD ml_NN tube_NN ._SENT The_DT beads_NNS were_VBD spun_VBN down_RP to_TO remove_VB the_DT supernatant_JJ and_CC washed_VBN five_CD times_NNS with_IN 5_CD ml_NN of_IN lysis_NN buffer_NN ,_, for_IN 15_CD min_NN each_DT ._SENT The_DT beads_NNS were_VBD then_RB transferred_VBN to_TO an_DT Ultrafree-MC_NP centrifugal_JJ filter_NN unit_NN ,_, 0.45_CD microm_NN in_IN size_NN (_( Millipore_NP )_) ,_, and_CC further_RBR washed_VBD three_CD times_NNS with_IN 400_CD microl_NN of_IN lysis_NN buffer_NN ._SENT Elution_NN was_VBD accomplished_VBN by_IN incubating_VBG with_IN 100_CD microl_NN of_IN lysis_NN buffer_NN containing_VBG 0.5_CD or_CC 5_CD mM_NP biotin_NN for_IN 1_CD h._JJ Northern_JJ blot_NN analysis_NN |_SYM Aliquots_NNS for_IN the_DT streptavidin_NN agarose_NN purification_NN were_VBD extracted_VBN from_IN column_NN fractions_NNS by_IN phenol_NN and_CC precipitated_VBD by_IN ethanol_NN ._SENT The_DT samples_NNS were_VBD separated_VBN by_IN a_DT 3_CD %_NN agarose_NN gel_NN and_CC then_RB transferred_VBN onto_IN a_DT positively_RB charged_VBN nylon_NN membrane_NN (_( Roche_NP )_) ._SENT The_DT northern_JJ blot_NN was_VBD performed_VBN with_IN Rapid-hyb_NP buffer_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ,_, using_VBG a_DT 5'-terminally_NN [_SYM 32P_JJ ]_SYM phosphorylated_JJ DNA_NN oligonucleotide_NN complementary_JJ to_TO positions_NNS 319_CD --_: 340_CD of_IN human_JJ RNase_NP P_NN RNA_NP or_CC 245_CD --_: 265_CD of_IN human_JJ RNase_NP MRP_NP RNA_NP ._SENT Western_JJ blot_NN analysis_NN |_SYM Samples_NP were_VBD separated_VBN in_IN 13_CD %_NN polyacrylamide_NN /0.1_CD %_NN SDS_NP gels_NNS ,_, electrotransferred_JJ to_TO a_DT nitrocellulose_NN filter_NN and_CC immunoblotted_JJ with_IN a_DT 1:100_CD dilution_NN of_IN the_DT primary_JJ antibody_NN serum_NN ._SENT As_IN a_DT secondary_JJ antibody_NN ,_, a_DT 1:5000_CD dilution_NN of_IN goat_NN anti-rabbit_JJ IgG_NP antibody_NN was_VBD used_VBN ._SENT Blots_NNS were_VBD washed_VBN and_CC antibody_NN --_: antigen_NN complexes_NNS were_VBD visualized_VBN with_IN ECL-Plus_NP detection_NN reagent_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ,_, following_VBG the_DT manufacturer_NN 's_POS instructions_NNS ._SENT The_DT membrane_NN was_VBD stripped_VBN of_IN bound_JJ antibodies_NNS and_CC reprobed_NN with_IN others_NNS ._SENT Enzyme_NN activity_NN assays_NNS |_SYM RNase_NP P_NN enzyme_NN activities_NNS were_VBD assayed_VBN in_IN 1x_NP PA_NP buffer_NN (_( 50_CD mM_NP Tris_NP --_: HCl_NP ,_, pH_NN 7.5_CD ,_, 10_CD mM_NP MgCl2_NP and_CC 100_CD mM_NP NH4Cl_NP )_) at_IN 37C_JJ ._SENT The_DT substrate_NN RNA_NP ,_, E.coli_NP precursor_NN tRNATyr_NN (_( pTyr_NN )_) ,_, was_VBD transcribed_VBN in_IN vitro_NN in_IN the_DT presence_NN of_IN [_SYM alpha-32P]GTP_NN ,_, purified_VBN on_IN a_DT 7_CD M_NP urea_NN 5_CD %_NN polyacrylamide_NN gel_NN ,_, and_CC used_VBN at_IN a_DT final_JJ concentration_NN of_IN 100_CD nM_NN (_( 2000_CD c.p.m._NN per_IN reaction_NN )_) ._SENT Figure_NP 1_CD |_SYM The_DT secondary_JJ structure_NN of_IN human_JJ nuclear_JJ RNase_NN P_NN from_IN HeLa_NP cells_NNS ._SENT The_DT secondary_JJ structure_NN of_IN human_JJ nuclear_JJ RNase_NN P_NN from_IN HeLa_NP cells_NNS ._SENT The_DT P3_NP domain_NN nucleotides_NNS are_VBP shown_VBN in_IN hollow_JJ letters_NNS ._SENT The_DT restriction_NN cleavage_NN site_NN for_IN ApaI_NP is_VBZ indicated_VBN as_IN an_DT arrow_NN ._SENT The_DT S1_NP aptamer_NN (_( rectangle_NN )_) with_IN an_DT extra_JJ stem_NN --_: loop_NN was_VBD inserted_VBN into_IN the_DT gene_NN for_IN H1_NP RNA_NP between_IN position_NN +207_JJ and_CC +214_JJ in_IN the_DT original_JJ sequence_NN in_IN the_DT construct_NN of_IN pDeltaEGFP_NN --_: H1S1_NP ._SENT The_DT main_JJ part_NN of_IN the_DT P3_NP domain_NN (_( from_IN +30_NN to_TO +67_NNS )_) was_VBD replaced_VBN additionally_RB by_IN a_DT tetraloop_NP AUGU_NP (_( see_NN circle_NN )_) in_IN the_DT construct_NN of_IN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT P12_NP extends_VBZ from_IN position_NN 155_CD to_TO position_VB 240_CD ._SENT Cloning_VBG and_CC transfection_NN of_IN the_DT RNA_NP subunit_NN |_SYM Helix_NP P12_NP of_IN H1_NP RNA_NP ,_, the_DT RNA_NP subunit_NN of_IN human_JJ nuclear_JJ RNase_NN P_NN ,_, is_VBZ not_RB conserved_VBN in_IN vertebrates_NNS ._SENT Accordingly_RB ,_, the_DT S1_NP aptamer_NN (_( shown_VBN in_IN the_DT rectangle_NN in_IN Fig._NN )_) with_IN an_DT extra_JJ stem_NN --_: loop_NN was_VBD incorporated_VBN between_IN the_DT nucleotides_NNS at_IN position_NN +207_JJ and_CC +214_JJ of_IN the_DT native_JJ H1_NP RNA_NP to_TO allow_VB for_IN function_NN of_IN the_DT whole_JJ H1_NP RNA_NP molecule_NN ._SENT The_DT first_JJ nucleotide_NN cloned_VBN is_VBZ the_DT 5_CD '_POS G_NN at_IN position_NN 208_CD and_CC the_DT last_JJ is_VBZ the_DT 3_CD '_POS G_NN at_IN position_NN 213_CD (_( see_VB Fig._NN for_IN tag_NN sequence_NN )_) ._SENT The_DT S1-tagged_NP H1_NP (_( H1S1_NP )_) gene_NN was_VBD placed_VBN into_IN a_DT mammalian_JJ expression_NN vector_NN pDeltaEGFP_NN which_WDT is_VBZ a_DT truncated_JJ version_NN of_IN pEGFP-N1_JJ (_( see_VB Materials_NNS and_CC Methods_NNS )_) ._SENT The_DT mutant_NN ,_, H1S1DeltaP3_NP ,_, which_WDT has_VBZ a_DT deletion_NN of_IN the_DT main_JJ part_NN of_IN the_DT P3_NP domain_NN of_IN H1_NP RNA_NP ,_, was_VBD also_RB cloned_VBN into_IN the_DT pDeltaEGFP_NN vector_NN ._SENT After_IN transfection_NN ,_, either_CC with_IN pDeltaEGFP_NN --_: H1S1_NP or_CC pDeltaEGFP_NP --_: H1S1DeltaP3_NP ,_, the_DT HeLa_NP cells_NNS had_VBD a_DT growth_NN phenotype_NN different_JJ from_IN cells_NNS without_IN transfection_NN or_CC transfected_JJ with_IN pEGFP-N1_NN ._SENT The_DT new_JJ cells_NNS transfected_VBN with_IN H1S1_NP RNA_NP or_CC H1S1DeltaP3_NP RNA_NP grew_VBD quite_RB slowly_RB (_( doubling_NN time_NN much_RB longer_JJR than_IN 24_CD h_NN ,_, the_DT usual_JJ doubling_NN time_NN of_IN these_DT cells_NNS )_) and_CC similar10_JJ %_NN of_IN them_PP died_VBD and_CC were_VBD washed_VBN away_RB by_IN PBS_NP washes_VBZ (_( see_VB Materials_NNS and_CC Methods_NNS )_) ._SENT The_DT slow_JJ growth_NN may_MD be_VB caused_VBN by_IN the_DT streptavidin_NN tag_NN in_IN H1_NP RNA_NP ._SENT Purification_NN by_IN streptavidin_JJ agarose_NN |_SYM The_DT crude_NN extracts_VBZ (_( S16_NP )_) of_IN transfected_JJ cells_NNS were_VBD bound_VBN to_TO streptavidin_NN agarose_NN and_CC extensively_RB washed_VBN with_IN lysis_NN buffer_NN (_( Materials_NNS and_CC Methods_NNS )_) ,_, and_CC then_RB eluted_VBN with_IN lysis_NN buffer_NN with_IN 0.5_CD mM_NNS and_CC then_RB 5_CD mM_NN biotin_NN ._SENT The_DT eluates_NNS were_VBD analyzed_VBN for_IN the_DT presence_NN of_IN H1_NP RNA_NP or_CC MRP_NP RNA_NP by_IN northern_JJ blot_NN hybridization_NN as_IN well_RB as_RB for_IN the_DT activity_NN of_IN RNase_NP P._NP The_DT H1S1_JJ transfected_JJ cell_NN extract_NN contained_VBD the_DT S1-tagged_JJ enzyme_NN ._SENT The_DT enzyme_NN bound_VBN to_TO streptavidin_NN agarose_NN and_CC was_VBD eluted_VBN with_IN 5_CD mM_NP biotin_NN ._SENT The_DT one-step_NN purification_NN fold_NN resulted_VBN in_IN an_DT similar410-fold_NN enrichment_NN of_IN the_DT RNase_NP P_NN activity_NN ,_, which_WDT is_VBZ close_JJ to_TO the_DT 510-fold_NN purification_NN achieved_VBN by_IN the_DT classic_JJ three-step_NN purification_NN [_SYM DEAE_NP Sepharose_NP ,_, glycerol_NN gradient_NN and_CC FPLC_NP monoQ_JJ column_NN ]_SYM ._SENT However_RB ,_, for_IN the_DT mutant_JJ H1S1DeltaP3_NP RNA_NP ,_, the_DT RNA_NP was_VBD isolated_VBN after_IN chromatography_NN (_( see_VB below_IN )_) but_CC no_DT active_JJ enzyme_NN was_VBD detected_VBN after_IN the_DT elution_NN ._SENT Subsequent_JJ to_TO the_DT streptavidin_NN agarose_NN column_NN ,_, the_DT RNase_NP P_NN with_IN the_DT tagged_VBN RNA_NP is_VBZ still_RB impure_JJ because_IN of_IN contaminating_VBG proteins_NNS that_WDT might_MD still_RB bind_VB to_TO H1_NP RNA_NP or_CC to_TO its_PP$ protein_NN subunits_NN ._SENT The_DT tagged_VBN RNA_NP enzyme_NN was_VBD then_RB subjected_VBN to_TO further_JJR chromatography_NN as_RB indicated_VBD by_IN the_DT conventional_JJ method_NN for_IN RNase_NP P_NN purification_NN ._SENT The_DT tagged_VBN RNA_NP enzyme_NN purification_NN behavior_NN is_VBZ shown_VBN in_IN Table_NP ,_, which_WDT shows_VBZ a_DT purification_NN of_IN 12_CD 000-fold_NN ._SENT The_DT final_JJ steps_NNS ,_, DEAE_NP Sepharose_NP ,_, FPLC_NP mono_JJ Q_NP and_CC Superose_NP 6_CD and_CC the_DT streptavidin_NN column_NN can_MD all_RB be_VB achieved_VBN in_IN 1_CD week_NN ,_, though_IN the_DT enzyme_NN is_VBZ not_RB yet_RB pure_JJ as_IN judged_VBN by_IN SDS_NP gel_NN electrophoresis_NN of_IN the_DT proteins_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT conventional_JJ method_NN ,_, including_VBG glycerol_NN gradients_NNS ,_, without_IN the_DT streptavidin_NN column_NN ,_, results_NNS in_IN a_DT purification_NN factor_NN of_IN 2300_CD and_CC takes_VBZ 1_CD month_NN ._SENT Northern_JJ blot_NN hybridization_NN |_SYM Northern_JJ blot_NN analysis_NN of_IN the_DT aliquots_NNS from_IN the_DT purification_NN step_NN revealed_VBD that_IN both_DT H1S1_NP and_CC H1S1DeltaP3_NP were_VBD found_VBN in_IN their_PP$ eluates_NNS of_IN 5_CD mM_NP biotin_NN from_IN the_DT agarose_JJ beads_NNS ,_, respectively_RB ._SENT MRP_NP RNA_NP ,_, which_WDT normally_RB associates_NNS with_IN RNase_NP P_NN in_IN the_DT early_JJ steps_NNS of_IN its_PP$ purification_NN ,_, was_VBD not_RB present_JJ in_IN the_DT eluates_NNS ._SENT It_PP should_MD be_VB noted_VBN that_IN the_DT expression_NN of_IN internal_JJ H1_NP RNA_NP was_VBD almost_RB completely_RB inhibited_VBN in_IN the_DT cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_NP (_( Fig._NN ,_, lane_NN 3_CD )_) ,_, but_CC not_RB in_IN those_DT transfected_NN with_IN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT Western_JJ blot_NN hybridization_NN |_SYM To_TO determine_VB whether_IN there_EX are_VBP protein_NN subunits_NN in_IN the_DT samples_NNS eluted_VBN from_IN streptavidin_NN columns_NNS ,_, western_JJ blots_NNS were_VBD done_VBN to_TO detect_VB eight_CD of_IN the_DT known_VBN protein_NN components_NNS (_( hPop1_NP ,_, Rpp40_NP ,_, Rpp38_NP ,_, Rpp30_NP ,_, Rpp29_NP ,_, Rpp25_NP ,_, Rpp21_NP and_CC Rpp20_NP )_) of_IN human_JJ nuclear_JJ RNase_NN P_NN by_IN their_PP$ cognate_JJ antibodies_NNS (_( --_: )_) ._SENT As_IN shown_VBN in_IN Figure_NN ,_, all_PDT the_DT proteins_NNS could_MD be_VB detected_VBN by_IN their_PP$ cognate_JJ antibodies_NNS in_IN the_DT 5_CD mM_NP biotin_NN eluate_NN of_IN cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_NP ,_, though_IN there_EX were_VBD two_CD proteins_NNS (_( Rpp38_NP and_CC Rpp29_NP )_) that_WDT showed_VBD weak_JJ signals_NNS ._SENT This_DT result_NN is_VBZ anticipated_VBN if_IN the_DT tagged_VBN RNA_NP is_VBZ part_NN of_IN an_DT active_JJ enzyme_NN ._SENT However_RB ,_, none_NN of_IN the_DT proteins_NNS could_MD be_VB detected_VBN in_IN the_DT corresponding_JJ sample_NN from_IN the_DT cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT Figure_NP 2_CD |_SYM RNase_NP P_NN activity_NN assay_NN of_IN fractions_NNS from_IN the_DT purification_NN step_NN of_IN streptavidin_NN agarose_NN chromatography_NN ._SENT RNase_NP P_NN activity_NN assay_NN of_IN fractions_NNS from_IN the_DT purification_NN step_NN of_IN streptavidin_NN agarose_NN chromatography_NN ._SENT Reaction_NN conditions_NNS are_VBP detailed_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT (_( A_NP )_) HeLa_NP cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_NP ._SENT Lane_NP 1_CD ,_, no_DT enzyme_NN ._SENT Lane_NP 2_CD ,_, S16_NP extract_NN ._SENT Lane_NP 3_CD ,_, the_DT supernatant_JJ after_IN rotation_NN with_IN streptavidin_NN agarose_NN overnight_RB ._SENT Lane_NP 4_CD ,_, the_DT streptavidin_NN column_NN flow_NN through_IN washed_VBN with_IN lysis_NN buffer_NN ._SENT Lane_NP 5_CD ,_, the_DT eluate_NNS (_( 0.5_CD mM_NP biotin_NN )_) ._SENT Lane_NP 6_CD ,_, the_DT eluate_NNS (_( 5_CD mM_NP biotin_NN )_) ._SENT Lane_NP 7_CD ,_, the_DT agarose_JJ beads_NNS assayed_VBN after_IN eluates_NNS ._SENT Lane_NP 8_CD ,_, RNase_NP P_NN purified_VBN by_IN conventional_JJ methods_NNS ._SENT (_( B_LS )_) The_DT same_JJ procedures_NNS except_IN extracts_VBZ of_IN HeLa_NP cells_NNS were_VBD transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT Figure_NP 3_CD |_SYM Northern_JJ blot_NN analysis_NN of_IN fractions_NNS from_IN the_DT purification_NN step_NN of_IN streptavidin_NN agarose_NN (_( Materials_NNS and_CC Methods_NNS )_) ._SENT Northern_JJ blot_NN analysis_NN of_IN fractions_NNS from_IN the_DT purification_NN step_NN of_IN streptavidin_NN agarose_NN (_( Materials_NNS and_CC Methods_NNS )_) ._SENT (_( A_NP )_) Northern_JJ blot_NN with_IN an_DT oligonucleotide_NN probe_NN against_IN RNase_NP P_NN RNA_NP ._SENT The_DT arrowhead_NN indicates_VBZ H1_NP RNA_NP and_CC the_DT arrow_NN indicates_VBZ H1S1_NP RNA_NP ._SENT (_( B_LS )_) Northern_JJ blot_NN with_IN an_DT oligonucleotide_NN probe_NN against_IN MRP_NP RNA_NP ._SENT The_DT left_VBN part_NN of_IN each_DT panel_NN is_VBZ from_IN HeLa_NP cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_NP whereas_IN the_DT right_JJ part_NN is_VBZ from_IN cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT Lane_NP 1_CD ,_, H1_NP RNA_NP transcribed_VBD in_IN vitro_NN by_IN T7_JJ RNA_NP polymerase_NN ._SENT Lane_NP 2_CD ,_, H1S1_NP RNA_NP transcribed_VBD in_IN vitro_NN by_IN T7_JJ RNA_NP polymerase_NN ._SENT Lane_NP 3_CD ,_, MRP_NP RNA_NP transcribed_VBD in_IN vitro_NN by_IN T7_JJ RNA_NP polymerase_NN ._SENT Lane_NP 4_CD ,_, S16_NP extract_NN of_IN HeLa_NP cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_NP (_( left_VBN )_) or_CC pDeltaEGFP_NN --_: H1S1DeltaP3_NP (_( right_NN )_) ._SENT Lane_NP 6_CD ,_, flow_NN through_IN washed_VBN with_IN lysis_NN buffer_NN ._SENT Lane_NP 7_CD ,_, the_DT eluate_NNS (_( 0.5_CD mM_NP biotin_NN )_) ._SENT Lane_NP 8_CD ,_, the_DT eluate_NNS (_( 5_CD mM_NP biotin_NN )_) ._SENT Lane_NP 9_CD ,_, agarose_JJ beads_NNS after_IN eluates_NNS ._SENT The_DT arrow_NN in_IN (_( B_NP )_) indicates_VBZ MRP_NP RNA_NP and_CC the_DT dots_NNS indicate_VBP fragments_NNS of_IN MRP_NP RNA_NP ._SENT Figure_NP 4_CD |_SYM Western_JJ blot_NN analysis_NN (_( Materials_NNS and_CC Methods_NNS )_) of_IN fractions_NNS from_IN the_DT purification_NN step_NN of_IN streptavidin_NN agarose_NN ._SENT Western_JJ blot_NN analysis_NN (_( Materials_NNS and_CC Methods_NNS )_) of_IN fractions_NNS from_IN the_DT purification_NN step_NN of_IN streptavidin_NN agarose_NN ._SENT The_DT blots_NNS have_VBP been_VBN probed_VBN with_IN antibodies_NNS to_TO the_DT various_JJ proteins_NNS listed_VBN between_IN the_DT columns_NNS of_IN figures_NNS ._SENT The_DT left_JJ part_NN is_VBZ from_IN HeLa_NP cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_NP whereas_IN the_DT right_JJ part_NN is_VBZ from_IN cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1DeltaP3_NP ._SENT Lane_NP 1_CD ,_, S16_NP extract_NN ._SENT Lane_NP 2_CD ,_, supernatant_JJ after_IN rotation_NN with_IN streptavidin_NN agarose_NN overnight_RB ._SENT Lane_NP 3_CD ,_, flow_NN through_IN washed_VBN with_IN lysis_NN buffer_NN ._SENT Lane_NP 4_CD ,_, the_DT eluate_NNS (_( 0.5_CD mM_NP biotin_NN )_) ._SENT Lane_NP 5_CD ,_, the_DT eluate_NNS (_( 5_CD mM_NP biotin_NN )_) ._SENT Lane_NP 6_CD ,_, agarose_JJ beads_NNS after_IN eluates_NNS ._SENT Table_NP 1_CD |_SYM Purification_NN profile_NN of_IN H1S1-tagged_JJ human_JJ RNase_NN P_NN from_IN HeLa_NP cells_NNS transfected_VBN with_IN pDeltaEGFP_NN --_: H1S1_JJ We_PP have_VBP shown_VBN that_IN the_DT S1-tagged_NP H1_NP RNA_NP could_MD reconstitute_VB with_IN RNase_NP P_NN proteins_NNS in_IN vivo_JJ to_TO form_VB an_DT active_JJ enzyme_NN ._SENT The_DT mutant_NN ,_, H1S1DeltaP3_NP ,_, the_DT P3_NP domain_NN of_IN which_WDT was_VBD deleted_VBN ,_, did_VBD not_RB yield_VB any_DT active_JJ enzyme_NN ._SENT The_DT S1-tagged_JJ enzyme_NN could_MD easily_RB be_VB separated_VBN from_IN the_DT native_JJ enzyme_NN by_IN a_DT one-step_NN streptavidin_NN agarose_NN column_NN with_IN a_DT 410-fold_JJ purification_NN ._SENT This_DT purification_NN achieves_VBZ what_WP a_DT three-step_NN conventional_JJ method_NN does_VBZ for_IN human_JJ nuclear_JJ RNase_NN P_NN ._SENT Eight_CD of_IN the_DT protein_NN components_NNS could_MD be_VB detected_VBN in_IN the_DT eluted_VBN sample_NN ._SENT Further_JJR purification_NN could_MD be_VB conducted_VBN by_IN DEAE_NP Sepharose_NP ,_, FPLC_NP monoQ_NP and_CC Superose_NP 6_CD ._SENT At_IN least_JJS five_CD protein_NN subunits_NN of_IN human_JJ RNase_NP P_NN ,_, namely_RB Rpp29_NP ,_, Rpp30_NP ,_, Rpp38_NP ,_, hPop1_NN and_CC hPop5_NN ,_, have_VBP been_VBN shown_VBN to_TO be_VB associated_VBN with_IN RNase_NP MRP_NP (_( --_: )_) ._SENT The_DT overlap_VBP of_IN subunit_NN composition_NN and_CC the_DT difficulty_NN in_IN separating_VBG easily_RB RNase_NN P_NN from_IN RNase_NP MRP_NP raised_VBD the_DT possibility_NN that_IN the_DT two_CD ribonucleoproteins_NNS might_MD be_VB in_IN the_DT same_JJ complex_NN in_IN vivo_RB ._SENT The_DT eluate_NN that_WDT contains_VBZ RNase_NN P_NN from_IN streptavidin_NN agarose_NN did_VBD not_RB contain_VB the_DT MRP_NP RNA_NP ,_, indicating_VBG that_IN the_DT RNase_NP P_NN and_CC MRP_NP were_VBD very_RB likely_RB not_RB associated_VBN with_IN each_DT other_JJ in_IN one_CD complex_NN ._SENT (_( We_PP assume_VBP that_DT lack_NN of_IN MRP_NP RNA_NP is_VBZ an_DT indication_NN that_IN no_DT functional_JJ RNase_NP MRP_NP is_VBZ in_IN the_DT fractions_NNS we_PP show_VBP in_IN the_DT figure_NN ._SENT )_) We_PP could_MD not_RB exclude_VB completely_RB the_DT possibility_NN that_IN the_DT S1_NP tag_NN affects_VBZ the_DT interaction_NN between_IN RNase_NP P_NN and_CC MRP_JJ in_IN vivo_RB ,_, if_IN there_EX is_VBZ any_DT ._SENT The_DT P3_NP domain_NN is_VBZ conserved_VBN in_IN nuclear_JJ RNase_NP P_NN and_CC MRP_JJ in_IN eukaryotic_JJ cells_NNS (_( ,_, )_) ._SENT This_DT domain_NN may_MD play_VB a_DT key_JJ role_NN in_IN the_DT entry_NN of_IN RNase_NP P_NN RNA_NP and_CC MRP_NP RNA_NP to_TO the_DT nucleolus_NN in_IN normal_JJ rat_NN kidney_NN epithelial_JJ cells_NNS (_( ,_, )_) ._SENT The_DT P3_NP domain_NN of_IN yeast_NN nuclear_JJ RNase_NP P_NN RNA_NP is_VBZ an_DT essential_JJ protein-binding_NN domain_NN ._SENT The_DT P3_NP domain_NN of_IN human_JJ nuclear_JJ RNase_NP P_NN RNA_NP interacts_VBZ with_IN Rpp21_NP ,_, Rpp29_NP ,_, Rpp30_NP and_CC Rpp38_NP in_IN vitro_NP by_IN UV_NP cross-linking_NN ,_, suggesting_VBG that_IN these_DT proteins_NNS are_VBP bound_VBN to_TO the_DT RNA_NP subunit_NN of_IN the_DT enzyme_NN ._SENT The_DT H1S1DeltaP3_NP RNA_NP was_VBD unable_JJ to_TO assemble_VB with_IN the_DT protein_NN subunits_NN of_IN RNase_NP P_NN to_TO produce_VB an_DT active_JJ enzyme_NN ._SENT This_DT result_NN indicated_VBD the_DT importance_NN of_IN the_DT P3_NP domain_NN of_IN RNase_NP P_NN in_IN the_DT assembly_NN and_CC function_NN of_IN nuclear_JJ RNase_NP P._NP There_RB are_VBP some_DT limits_NNS on_IN the_DT tagged_VBN RNA_NP purification_NN method_NN ._SENT The_DT prime_JJ concern_NN is_VBZ that_IN a_DT stable_JJ HeLa_NP cell_NN strain_NN could_MD not_RB be_VB obtained_VBN by_IN transfection_NN with_IN pDeltaEGFP_NN --_: H1S1_NP ._SENT A_DT similar_JJ event_NN happened_VBN with_IN plasmid_NP pmU6-H1S1_NN using_VBG a_DT mouse_NN U6_NN promoter_NN and_CC pEGFP_NN --_: H1S1_NP (_( data_NN not_RB shown_VBN )_) ._SENT This_DT phenomenon_NN might_MD be_VB connected_VBN to_TO the_DT fact_NN that_IN H1S1_NP RNA_NP expression_NN can_MD inhibit_VB native_JJ H1_NP RNA_NP expression_NN and_CC ,_, therefore_RB ,_, must_MD have_VB effects_NNS on_IN cell_NN survival_NN ._SENT The_DT streptavidin_NN tag_NN method_NN offers_VBZ further_JJR opportunities_NNS for_IN studying_VBG the_DT roles_NNS of_IN particular_JJ segments_NNS of_IN the_DT RNA_NP in_IN enzyme_NN function_NN ,_, and_CC for_IN purification_NN of_IN RNase_NP P_NN free_JJ of_IN RNase_NP MRP_NP ._SENT A_DT streptavidin_NN tag_NN has_VBZ been_VBN inserted_VBN into_IN a_DT segment_NN of_IN H1_NP RNA_NP ,_, the_DT RNA_NP component_NN of_IN human_JJ nuclear_JJ RNase_NN P_NN ,_, and_CC has_VBZ facilitated_VBN the_DT purification_NN of_IN an_DT intact_JJ enzyme_NN from_IN crude_JJ cell_NN extracts_VBZ ._SENT This_DT simple_JJ procedure_NN has_VBZ yielded_VBN an_DT enzyme_NN that_WDT is_VBZ free_JJ of_IN human_JJ RNase_NP MRP_NP and_CC allows_VBZ further_JJR steps_NNS in_IN purification_NN ._SENT A_DT streptavidin_NN tag_NN of_IN H1_NP RNA_NP that_WDT is_VBZ missing_VBG the_DT deleted_VBN P3_NP helix_NN does_VBZ not_RB yield_VB RNase_NP P._NP The_DT method_NN is_VBZ therefore_RB useful_JJ for_IN testing_VBG different_JJ parts_NNS of_IN H1_NP RNA_NP for_IN function_NN and_CC as_IN a_DT part_NN of_IN a_DT purification_NN procedure_NN ._SENT 